2024-04-012025-03-312025-03-31false11254819FLORENCE ORGANICS LTD2025-10-07falseiso4217:GBPxbrli:pure112548192024-03-31112548192025-03-31112548192024-04-012025-03-31112548192023-03-31112548192024-03-31112548192023-04-012024-03-3111254819bus:SmallEntities2024-04-012025-03-3111254819bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3111254819bus:FullAccounts2024-04-012025-03-3111254819bus:PrivateLimitedCompanyLtd2024-04-012025-03-3111254819core:WithinOneYear2025-03-3111254819core:AfterOneYear2025-03-3111254819core:WithinOneYear2024-03-3111254819core:AfterOneYear2024-03-3111254819core:ShareCapital2025-03-3111254819core:SharePremium2025-03-3111254819core:RevaluationReserve2025-03-3111254819core:OtherReservesSubtotal2025-03-3111254819core:RetainedEarningsAccumulatedLosses2025-03-3111254819core:ShareCapital2024-03-3111254819core:SharePremium2024-03-3111254819core:RevaluationReserve2024-03-3111254819core:OtherReservesSubtotal2024-03-3111254819core:RetainedEarningsAccumulatedLosses2024-03-3111254819core:LandBuildings2025-03-3111254819core:PlantMachinery2025-03-3111254819core:Vehicles2025-03-3111254819core:FurnitureFittings2025-03-3111254819core:OfficeEquipment2025-03-3111254819core:NetGoodwill2025-03-3111254819core:IntangibleAssetsOtherThanGoodwill2025-03-3111254819core:ListedExchangeTraded2025-03-3111254819core:UnlistedNon-exchangeTraded2025-03-3111254819core:LandBuildings2024-03-3111254819core:PlantMachinery2024-03-3111254819core:Vehicles2024-03-3111254819core:FurnitureFittings2024-03-3111254819core:OfficeEquipment2024-03-3111254819core:NetGoodwill2024-03-3111254819core:IntangibleAssetsOtherThanGoodwill2024-03-3111254819core:ListedExchangeTraded2024-03-3111254819core:UnlistedNon-exchangeTraded2024-03-3111254819core:LandBuildings2024-04-012025-03-3111254819core:PlantMachinery2024-04-012025-03-3111254819core:Vehicles2024-04-012025-03-3111254819core:FurnitureFittings2024-04-012025-03-3111254819core:OfficeEquipment2024-04-012025-03-3111254819core:NetGoodwill2024-04-012025-03-3111254819core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3111254819core:ListedExchangeTraded2024-04-012025-03-3111254819core:UnlistedNon-exchangeTraded2024-04-012025-03-3111254819core:MoreThanFiveYears2024-04-012025-03-3111254819core:Non-currentFinancialInstruments2025-03-3111254819core:Non-currentFinancialInstruments2024-03-3111254819dpl:CostSales2024-04-012025-03-3111254819dpl:DistributionCosts2024-04-012025-03-3111254819core:LandBuildings2024-04-012025-03-3111254819core:PlantMachinery2024-04-012025-03-3111254819core:Vehicles2024-04-012025-03-3111254819core:FurnitureFittings2024-04-012025-03-3111254819core:OfficeEquipment2024-04-012025-03-3111254819dpl:AdministrativeExpenses2024-04-012025-03-3111254819core:NetGoodwill2024-04-012025-03-3111254819core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3111254819dpl:GroupUndertakings2024-04-012025-03-3111254819dpl:ParticipatingInterests2024-04-012025-03-3111254819dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3111254819core:ListedExchangeTraded2024-04-012025-03-3111254819dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3111254819core:UnlistedNon-exchangeTraded2024-04-012025-03-3111254819dpl:CostSales2023-04-012024-03-3111254819dpl:DistributionCosts2023-04-012024-03-3111254819core:LandBuildings2023-04-012024-03-3111254819core:PlantMachinery2023-04-012024-03-3111254819core:Vehicles2023-04-012024-03-3111254819core:FurnitureFittings2023-04-012024-03-3111254819core:OfficeEquipment2023-04-012024-03-3111254819dpl:AdministrativeExpenses2023-04-012024-03-3111254819core:NetGoodwill2023-04-012024-03-3111254819core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3111254819dpl:GroupUndertakings2023-04-012024-03-3111254819dpl:ParticipatingInterests2023-04-012024-03-3111254819dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3111254819core:ListedExchangeTraded2023-04-012024-03-3111254819dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3111254819core:UnlistedNon-exchangeTraded2023-04-012024-03-3111254819core:NetGoodwill2025-03-3111254819core:IntangibleAssetsOtherThanGoodwill2025-03-3111254819core:LandBuildings2025-03-3111254819core:PlantMachinery2025-03-3111254819core:Vehicles2025-03-3111254819core:FurnitureFittings2025-03-3111254819core:OfficeEquipment2025-03-3111254819core:AfterOneYear2025-03-3111254819core:WithinOneYear2025-03-3111254819core:ListedExchangeTraded2025-03-3111254819core:UnlistedNon-exchangeTraded2025-03-3111254819core:ShareCapital2025-03-3111254819core:SharePremium2025-03-3111254819core:RevaluationReserve2025-03-3111254819core:OtherReservesSubtotal2025-03-3111254819core:RetainedEarningsAccumulatedLosses2025-03-3111254819core:NetGoodwill2024-03-3111254819core:IntangibleAssetsOtherThanGoodwill2024-03-3111254819core:LandBuildings2024-03-3111254819core:PlantMachinery2024-03-3111254819core:Vehicles2024-03-3111254819core:FurnitureFittings2024-03-3111254819core:OfficeEquipment2024-03-3111254819core:AfterOneYear2024-03-3111254819core:WithinOneYear2024-03-3111254819core:ListedExchangeTraded2024-03-3111254819core:UnlistedNon-exchangeTraded2024-03-3111254819core:ShareCapital2024-03-3111254819core:SharePremium2024-03-3111254819core:RevaluationReserve2024-03-3111254819core:OtherReservesSubtotal2024-03-3111254819core:RetainedEarningsAccumulatedLosses2024-03-3111254819core:NetGoodwill2023-03-3111254819core:IntangibleAssetsOtherThanGoodwill2023-03-3111254819core:LandBuildings2023-03-3111254819core:PlantMachinery2023-03-3111254819core:Vehicles2023-03-3111254819core:FurnitureFittings2023-03-3111254819core:OfficeEquipment2023-03-3111254819core:AfterOneYear2023-03-3111254819core:WithinOneYear2023-03-3111254819core:ListedExchangeTraded2023-03-3111254819core:UnlistedNon-exchangeTraded2023-03-3111254819core:ShareCapital2023-03-3111254819core:SharePremium2023-03-3111254819core:RevaluationReserve2023-03-3111254819core:OtherReservesSubtotal2023-03-3111254819core:RetainedEarningsAccumulatedLosses2023-03-3111254819core:AfterOneYear2024-04-012025-03-3111254819core:WithinOneYear2024-04-012025-03-3111254819core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3111254819core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3111254819core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3111254819core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3111254819core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3111254819core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3111254819core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3111254819core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3111254819core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3111254819core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3111254819core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3111254819core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3111254819core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3111254819core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3111254819core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3111254819core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3111254819core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3111254819core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3111254819core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3111254819core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3111254819core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3111254819core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3111254819core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3111254819core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3111254819core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3111254819core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3111254819core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3111254819bus:Director12024-04-012025-03-3111254819bus:Director22024-04-012025-03-31112548191bus:Director12024-03-31112548191bus:Director12024-04-012025-03-31112548191bus:Director12025-03-31112548192bus:Director22024-03-31112548192bus:Director22024-04-012025-03-31112548192bus:Director22025-03-31112548192024-03-31112548192024-04-012025-03-31112548192025-03-31

FLORENCE ORGANICS LTD

Registered Number
11254819
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

FLORENCE ORGANICS LTD
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

Mr Giampaolo Floris
Mr Antonio Vidili

Registered Address

Office 5 The Round House
Dormans Park Road
East Grinstead
RH19 2EN

Registered Number

11254819 (England and Wales)
FLORENCE ORGANICS LTD
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets412,00722,530
12,00722,530
Current assets
Stocks5955,509536,407
Debtors6445,567445,346
Cash at bank and on hand250,841362,890
1,651,9171,344,643
Creditors amounts falling due within one year7(51,847)(30,738)
Net current assets (liabilities)1,600,0701,313,905
Total assets less current liabilities1,612,0771,336,435
Net assets1,612,0771,336,435
Capital and reserves
Called up share capital22
Profit and loss account1,612,0751,336,433
Shareholders' funds1,612,0771,336,435
The financial statements were approved and authorised for issue by the Board of Directors on 7 October 2025, and are signed on its behalf by:
Mr Antonio Vidili
Director
Mr Giampaolo Floris
Director

Registered Company No. 11254819
FLORENCE ORGANICS LTD
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Interest income
Interest income is recognised using the effective interest rate method.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Amortisation
The following amortisation rates are used for Intangible assets: Trade Mark's less than £500 100% in first year Trade Mark's over £500 10% straight line.
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
Trade and other debtors
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business. Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Trade creditors Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities. Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method. Borrowings Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing. Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges. Borrowings are classified as current liabilities unless the company has a
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20252024
Average number of employees during the year22
3.Deferred tax
Increases in the UK Corporation tax rate from 19% to 25% (19% effective from 1 April 2017, and 25% effective from 1 April 2023) have been substantively enacted. This will impact the company's future tax charge accordingly. The value of the deferred tax assets at the balance sheet date has been calculated using the applicable rate when the asset is expected to be realised.
4.Intangible assets

Other

Total

££
Cost or valuation
At 01 April 2422,53022,530
At 31 March 2522,53022,530
Amortisation and impairment
Charge for year10,52310,523
At 31 March 2510,52310,523
Net book value
At 31 March 2512,00712,007
At 31 March 2422,53022,530
5.Stocks

2025

2024

££
Finished goods955,509536,407
Total955,509536,407
6.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables132,541214,514
Other debtors306,395222,884
Prepayments and accrued income6,6317,948
Total445,567445,346
7.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables68317,624
Taxation and social security51,16113,107
Other creditors37
Total51,84730,738
8.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
Mr Giampaolo Floris67,5667,73375,2990
Mr Antonio Vidili51,158051,1580
118,7247,733126,4570
The loans were interest free and had no fixed repayment terms.
9.Related party transactions
The following balances with related parties subsisted at the balance sheet date: Florence Organics LLC - a company under common control: A loan from Florence Organics Ltd of £51,377.81 (2024 £34,209.10) is included in other debtors. Additionally Included in Trade Debtors was £75,213.16 (2024 Nil). Floris Creations Ltd - a company which one of the directors has a shareholding owed Florence Organics Ltd £5,508.29 (2024 £5,508.29) and this is included in other debtors.